PTEN and Parkinson disease: One study found that PTEN can act as an upstream activator of Fyn kinase, leading to the death of dopaminergic neurons and activation of neuroinflammatory pathways, and suggested that PTEN may be a therapeutic target for PD using pharmacological inhibitors of PTEN (Johnson et al., 2023).